Anti-tuberculosis Therapeutics Market
The global Anti-tuberculosis Therapeutics market size was valued at US$ 1.23 billion in 2024 and is projected to reach US$ 1.67 billion by 2030, at a CAGR of 5.2% during the forecast period 2024-2030.
United States Anti-tuberculosis Therapeutics market size was valued at US$ 333 million in 2024 and is projected to reach US$ 437 million by 2030, at a CAGR of 4.6% during the forecast period 2024-2030.
Medications used to treat and prevent tuberculosis.
Report Overview
Tuberculosis (TB) is a disease affecting the population across the world. Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in the emerging economies.
This report provides a deep insight into the global Anti-tuberculosis Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-tuberculosis Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-tuberculosis Therapeutics market in any manner.
Global Anti-tuberculosis Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline
Merck
Sanofi
Market Segmentation (by Type)
Isoniazid
Rifampin
Ethambutol
Pyrazinamide
Otherr
Market Segmentation (by Application)
Hospitals and Clinics
Government Agencies
Non-Profit Organizations
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Anti-tuberculosis Therapeutics Market
Overview of the regional outlook of the Anti-tuberculosis Therapeutics Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Anti-tuberculosis Therapeutics
1.2 Key Market Segments
1.2.1 Anti-tuberculosis Therapeutics Segment by Type
1.2.2 Anti-tuberculosis Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Anti-tuberculosis Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Anti-tuberculosis Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anti-tuberculosis Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Anti-tuberculosis Therapeutics Market Competitive Landscape
3.1 Global Anti-tuberculosis Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Anti-tuberculosis Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-tuberculosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-tuberculosis Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-tuberculosis Therapeutics Sales Sites, Area Served, Product Type
3.6 Anti-tuberculosis Therapeutics Market Competitive Situation and Trends
3.6.1 Anti-tuberculosis Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-tuberculosis Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Anti-tuberculosis Therapeutics Industry Chain Analysis
4.1 Anti-tuberculosis Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Anti-tuberculosis Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Anti-tuberculosis Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-tuberculosis Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Anti-tuberculosis Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Anti-tuberculosis Therapeutics Price by Type (2019-2024)
7 Anti-tuberculosis Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-tuberculosis Therapeutics Market Sales by Application (2019-2024)
7.3 Global Anti-tuberculosis Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-tuberculosis Therapeutics Sales Growth Rate by Application (2019-2024)
8 Anti-tuberculosis Therapeutics Market Segmentation by Region
8.1 Global Anti-tuberculosis Therapeutics Sales by Region
8.1.1 Global Anti-tuberculosis Therapeutics Sales by Region
8.1.2 Global Anti-tuberculosis Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-tuberculosis Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-tuberculosis Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-tuberculosis Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-tuberculosis Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-tuberculosis Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Lupin
9.1.1 Lupin Anti-tuberculosis Therapeutics Basic Information
9.1.2 Lupin Anti-tuberculosis Therapeutics Product Overview
9.1.3 Lupin Anti-tuberculosis Therapeutics Product Market Performance
9.1.4 Lupin Business Overview
9.1.5 Lupin Anti-tuberculosis Therapeutics SWOT Analysis
9.1.6 Lupin Recent Developments
9.2 Macleods Pharmaceuticals
9.2.1 Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Basic Information
9.2.2 Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Product Overview
9.2.3 Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Product Market Performance
9.2.4 Macleods Pharmaceuticals Business Overview
9.2.5 Macleods Pharmaceuticals Anti-tuberculosis Therapeutics SWOT Analysis
9.2.6 Macleods Pharmaceuticals Recent Developments
9.3 Otsuka Pharmaceutical
9.3.1 Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Basic Information
9.3.2 Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Product Overview
9.3.3 Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Product Market Performance
9.3.4 Otsuka Pharmaceutical Anti-tuberculosis Therapeutics SWOT Analysis
9.3.5 Otsuka Pharmaceutical Business Overview
9.3.6 Otsuka Pharmaceutical Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Anti-tuberculosis Therapeutics Basic Information
9.4.2 Johnson and Johnson Anti-tuberculosis Therapeutics Product Overview
9.4.3 Johnson and Johnson Anti-tuberculosis Therapeutics Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Recent Developments
9.5 Pfizer
9.5.1 Pfizer Anti-tuberculosis Therapeutics Basic Information
9.5.2 Pfizer Anti-tuberculosis Therapeutics Product Overview
9.5.3 Pfizer Anti-tuberculosis Therapeutics Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Recent Developments
9.6 Novartis
9.6.1 Novartis Anti-tuberculosis Therapeutics Basic Information
9.6.2 Novartis Anti-tuberculosis Therapeutics Product Overview
9.6.3 Novartis Anti-tuberculosis Therapeutics Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Abbott
9.7.1 Abbott Anti-tuberculosis Therapeutics Basic Information
9.7.2 Abbott Anti-tuberculosis Therapeutics Product Overview
9.7.3 Abbott Anti-tuberculosis Therapeutics Product Market Performance
9.7.4 Abbott Business Overview
9.7.5 Abbott Recent Developments
9.8 AstraZeneca
9.8.1 AstraZeneca Anti-tuberculosis Therapeutics Basic Information
9.8.2 AstraZeneca Anti-tuberculosis Therapeutics Product Overview
9.8.3 AstraZeneca Anti-tuberculosis Therapeutics Product Market Performance
9.8.4 AstraZeneca Business Overview
9.8.5 AstraZeneca Recent Developments
9.9 Bayer
9.9.1 Bayer Anti-tuberculosis Therapeutics Basic Information
9.9.2 Bayer Anti-tuberculosis Therapeutics Product Overview
9.9.3 Bayer Anti-tuberculosis Therapeutics Product Market Performance
9.9.4 Bayer Business Overview
9.9.5 Bayer Recent Developments
9.10 Eli Lilly
9.10.1 Eli Lilly Anti-tuberculosis Therapeutics Basic Information
9.10.2 Eli Lilly Anti-tuberculosis Therapeutics Product Overview
9.10.3 Eli Lilly Anti-tuberculosis Therapeutics Product Market Performance
9.10.4 Eli Lilly Business Overview
9.10.5 Eli Lilly Recent Developments
9.11 GlaxoSmithKline
9.11.1 GlaxoSmithKline Anti-tuberculosis Therapeutics Basic Information
9.11.2 GlaxoSmithKline Anti-tuberculosis Therapeutics Product Overview
9.11.3 GlaxoSmithKline Anti-tuberculosis Therapeutics Product Market Performance
9.11.4 GlaxoSmithKline Business Overview
9.11.5 GlaxoSmithKline Recent Developments
9.12 Merck
9.12.1 Merck Anti-tuberculosis Therapeutics Basic Information
9.12.2 Merck Anti-tuberculosis Therapeutics Product Overview
9.12.3 Merck Anti-tuberculosis Therapeutics Product Market Performance
9.12.4 Merck Business Overview
9.12.5 Merck Recent Developments
9.13 Sanofi
9.13.1 Sanofi Anti-tuberculosis Therapeutics Basic Information
9.13.2 Sanofi Anti-tuberculosis Therapeutics Product Overview
9.13.3 Sanofi Anti-tuberculosis Therapeutics Product Market Performance
9.13.4 Sanofi Business Overview
9.13.5 Sanofi Recent Developments
10 Anti-tuberculosis Therapeutics Market Forecast by Region
10.1 Global Anti-tuberculosis Therapeutics Market Size Forecast
10.2 Global Anti-tuberculosis Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-tuberculosis Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Anti-tuberculosis Therapeutics Market Size Forecast by Region
10.2.4 South America Anti-tuberculosis Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anti-tuberculosis Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Anti-tuberculosis Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anti-tuberculosis Therapeutics by Type (2025-2030)
11.1.2 Global Anti-tuberculosis Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anti-tuberculosis Therapeutics by Type (2025-2030)
11.2 Global Anti-tuberculosis Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Anti-tuberculosis Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Anti-tuberculosis Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-tuberculosis Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Anti-tuberculosis Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Anti-tuberculosis Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-tuberculosis Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-tuberculosis Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tuberculosis Therapeutics as of 2022)
Table 10. Global Market Anti-tuberculosis Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-tuberculosis Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Anti-tuberculosis Therapeutics Product Type
Table 13. Global Anti-tuberculosis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-tuberculosis Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-tuberculosis Therapeutics Market Challenges
Table 22. Global Anti-tuberculosis Therapeutics Sales by Type (K Units)
Table 23. Global Anti-tuberculosis Therapeutics Market Size by Type (M USD)
Table 24. Global Anti-tuberculosis Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Anti-tuberculosis Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Anti-tuberculosis Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-tuberculosis Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Anti-tuberculosis Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Anti-tuberculosis Therapeutics Sales (K Units) by Application
Table 30. Global Anti-tuberculosis Therapeutics Market Size by Application
Table 31. Global Anti-tuberculosis Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Anti-tuberculosis Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Anti-tuberculosis Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-tuberculosis Therapeutics Market Share by Application (2019-2024)
Table 35. Global Anti-tuberculosis Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-tuberculosis Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Anti-tuberculosis Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Anti-tuberculosis Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Anti-tuberculosis Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Anti-tuberculosis Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Anti-tuberculosis Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Anti-tuberculosis Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Lupin Anti-tuberculosis Therapeutics Basic Information
Table 44. Lupin Anti-tuberculosis Therapeutics Product Overview
Table 45. Lupin Anti-tuberculosis Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Lupin Business Overview
Table 47. Lupin Anti-tuberculosis Therapeutics SWOT Analysis
Table 48. Lupin Recent Developments
Table 49. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Basic Information
Table 50. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Product Overview
Table 51. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Macleods Pharmaceuticals Business Overview
Table 53. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics SWOT Analysis
Table 54. Macleods Pharmaceuticals Recent Developments
Table 55. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Basic Information
Table 56. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Product Overview
Table 57. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics SWOT Analysis
Table 59. Otsuka Pharmaceutical Business Overview
Table 60. Otsuka Pharmaceutical Recent Developments
Table 61. Johnson and Johnson Anti-tuberculosis Therapeutics Basic Information
Table 62. Johnson and Johnson Anti-tuberculosis Therapeutics Product Overview
Table 63. Johnson and Johnson Anti-tuberculosis Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Johnson and Johnson Business Overview
Table 65. Johnson and Johnson Recent Developments
Table 66. Pfizer Anti-tuberculosis Therapeutics Basic Information
Table 67. Pfizer Anti-tuberculosis Therapeutics Product Overview
Table 68. Pfizer Anti-tuberculosis Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Pfizer Business Overview
Table 70. Pfizer Recent Developments
Table 71. Novartis Anti-tuberculosis Therapeutics Basic Information
Table 72. Novartis Anti-tuberculosis Therapeutics Product Overview
Table 73. Novartis Anti-tuberculosis Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Abbott Anti-tuberculosis Therapeutics Basic Information
Table 77. Abbott Anti-tuberculosis Therapeutics Product Overview
Table 78. Abbott Anti-tuberculosis Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Abbott Business Overview
Table 80. Abbott Recent Developments
Table 81. AstraZeneca Anti-tuberculosis Therapeutics Basic Information
Table 82. AstraZeneca Anti-tuberculosis Therapeutics Product Overview
Table 83. AstraZeneca Anti-tuberculosis Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. AstraZeneca Business Overview
Table 85. AstraZeneca Recent Developments
Table 86. Bayer Anti-tuberculosis Therapeutics Basic Information
Table 87. Bayer Anti-tuberculosis Therapeutics Product Overview
Table 88. Bayer Anti-tuberculosis Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Bayer Business Overview
Table 90. Bayer Recent Developments
Table 91. Eli Lilly Anti-tuberculosis Therapeutics Basic Information
Table 92. Eli Lilly Anti-tuberculosis Therapeutics Product Overview
Table 93. Eli Lilly Anti-tuberculosis Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Eli Lilly Business Overview
Table 95. Eli Lilly Recent Developments
Table 96. GlaxoSmithKline Anti-tuberculosis Therapeutics Basic Information
Table 97. GlaxoSmithKline Anti-tuberculosis Therapeutics Product Overview
Table 98. GlaxoSmithKline Anti-tuberculosis Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. GlaxoSmithKline Business Overview
Table 100. GlaxoSmithKline Recent Developments
Table 101. Merck Anti-tuberculosis Therapeutics Basic Information
Table 102. Merck Anti-tuberculosis Therapeutics Product Overview
Table 103. Merck Anti-tuberculosis Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Merck Business Overview
Table 105. Merck Recent Developments
Table 106. Sanofi Anti-tuberculosis Therapeutics Basic Information
Table 107. Sanofi Anti-tuberculosis Therapeutics Product Overview
Table 108. Sanofi Anti-tuberculosis Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Sanofi Business Overview
Table 110. Sanofi Recent Developments
Table 111. Global Anti-tuberculosis Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Anti-tuberculosis Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Anti-tuberculosis Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Anti-tuberculosis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Anti-tuberculosis Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Anti-tuberculosis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Anti-tuberculosis Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Anti-tuberculosis Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Anti-tuberculosis Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Anti-tuberculosis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Anti-tuberculosis Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Anti-tuberculosis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Anti-tuberculosis Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Anti-tuberculosis Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Anti-tuberculosis Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Anti-tuberculosis Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Anti-tuberculosis Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Anti-tuberculosis Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-tuberculosis Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Anti-tuberculosis Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Anti-tuberculosis Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-tuberculosis Therapeutics Market Size by Country (M USD)
Figure 11. Anti-tuberculosis Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Anti-tuberculosis Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Anti-tuberculosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-tuberculosis Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-tuberculosis Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-tuberculosis Therapeutics Market Share by Type
Figure 18. Sales Market Share of Anti-tuberculosis Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Anti-tuberculosis Therapeutics by Type in 2023
Figure 20. Market Size Share of Anti-tuberculosis Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-tuberculosis Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-tuberculosis Therapeutics Market Share by Application
Figure 24. Global Anti-tuberculosis Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-tuberculosis Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Anti-tuberculosis Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Anti-tuberculosis Therapeutics Market Share by Application in 2023
Figure 28. Global Anti-tuberculosis Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-tuberculosis Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Anti-tuberculosis Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Anti-tuberculosis Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-tuberculosis Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Anti-tuberculosis Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Anti-tuberculosis Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Anti-tuberculosis Therapeutics Sales Market Share by Region in 2023
Figure 44. China Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Anti-tuberculosis Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Anti-tuberculosis Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Anti-tuberculosis Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Anti-tuberculosis Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Anti-tuberculosis Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Anti-tuberculosis Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Anti-tuberculosis Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anti-tuberculosis Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anti-tuberculosis Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Anti-tuberculosis Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Anti-tuberculosis Therapeutics Market Share Forecast by Application (2025-2030)
